While further studies are needed to validate these promising results, our findings pave the way for new therapeutic approaches in patients with overgrowth syndromes and vascular anomalies caused by PIK3R1 variants involving the iSH2 domain. The gene discussed is PIK3R1; the disease is overgrowth syndrome.